Skip to main content

IV Equipment Market to Reflect Impressive Growth in North America and Europe

Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein. They can deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. Presently, many companies are developing various infusion devices capable of being integrated with alarm devices, monitoring devices, and data exchange systems.

  •  The overall IV equipment market is expected to grow from USD 10.07 billion in 2017 to USD 13.64 billion by 2022, at a CAGR of 6.2% from 2017 to 2022.

Browse in-depth TOC on “IV Equipment Market”
102 – Tables
38 – Figures
166 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78345313


IV Equipment Market is estimated to be the largest segment for the market

The major factors driving the growth of this market include increasing incidence of chronic diseases, rapid growth in the aging population, and growing number of surgical procedures. The high growth in developing countries across Asia-Pacific and Latin America are expected to provide significant growth opportunities for players operating in the IV equipment market in the coming years. However, stringent regulatory requirements for new products and increasing incidence of medication errors and lack of wireless connectivity in most hospitals pose challenges for the growth of this market.

IV catheters to hold the largest market share during the forecast period

Based on product, the IV equipment market is segmented into IV catheters, administration sets, infusion pumps, securement devices, stopcocks & check valves, drip chambers, needleless connectors, and others. In 2016, the IV catheters accounted for the largest share of the market. Increasing prevalence of chronic diseases and the growing number of surgical procedures are the key factors driving the market growth in this segment.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=78345313

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

North America is expected to be the fastest-growing market for IV Equipment

North America accounted for the largest share of the global IV equipment market, followed by Europe, Asia-Pacific, and RoW. This growth can be attributed to the rising geriatric population, increasing prevalence of chronic diseases, the presence of a well-established healthcare industry, growing demand for advanced medical treatments, the presence of major players, and increasing government healthcare expenditure.

Some key players mentioned in the research report are:

Some of the prominent players in the global IV equipment market are Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (U.S.) held the major share of the IV equipment market and will continue to dominate the market between 2017 and 2022. Other major players operating in this market are Smiths Medical (U.K.), Moog, Inc. (U.S.), Terumo Corporation (Japan.), C. R. Bard, Inc. (U.S.), and AngioDynamics, Inc. (U.S.).

Labels:

Comments

Post a Comment

Popular posts from this blog

Biomaterials Market To Reach USD 47.5 billion by 2025 - Rising demand for medical implants

  What This Report Will Provide? This study involved four major activities in estimating the current size of the biomaterials market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Expected Revenue Growth: [298 Pages Report]  The global  biomaterials market  size is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period. Major Growth Boosters: Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing res...
Post a Comment
Read more

Benefits of Best Accounting Software by 360Quadrants

  Accounting software  can manage the businesses in several different ways, based on the key characteristics and goals. Accounting systems provide all kinds of bonuses, from simpler invoicing to complicated tax reporting, that is not even possible without a correct framework. Simplification  - Accounting software put control of funds in the hands of a non-accounting crowd, aimed at giving significance to statistics while executing electronic computations. With hardly any training, the company owner can execute all financial transactions and meet the legal requirements from a desktop computer or smartphone, even without having to pay a third party to keep the expenditure in the loop. Cost reduction  - Accounting and finance frameworks simplify key estimates and operating processes and gain a charge of the sales process and you don't need to outsource financial services to an external specialist. They also raise printing and storage prices and store confidential data i...
Post a Comment
Read more

Biomaterials Market To Reach $ 47.5 Billion – Increasing Research On Regenerative Medicine

  Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine. In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years. [298 Pages Report]  The  global biomaterials market  size is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period. Market Dynamics Increased funds and grants by government bodies and universities for the development of novel biomaterials Increasing demand for implantable devices Growing demand for biomaterials in plastic surgery and wound healing applications Rising incidence of cardiovascular diseases Increasing research on regenerative medic...
Post a Comment
Read more